List of Tables
Table 1. Global Lung Cancer Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Lung Cancer Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Lung Cancer Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Lung Cancer Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Lung Cancer Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Lung Cancer Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Lung Cancer Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Lung Cancer Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Lung Cancer Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Lung Cancer Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Lung Cancer Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Lung Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Lung Cancer Vaccine Sales by Region (2017-2022) & (K Units)
Table 16. Global Lung Cancer Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Lung Cancer Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Lung Cancer Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Lung Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 20. North America Lung Cancer Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Lung Cancer Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Lung Cancer Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Lung Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Lung Cancer Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Lung Cancer Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Lung Cancer Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Lung Cancer Vaccine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Lung Cancer Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Lung Cancer Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Lung Cancer Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Lung Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Lung Cancer Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Lung Cancer Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Lung Cancer Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Lung Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Lung Cancer Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Lung Cancer Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Lung Cancer Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Lung Cancer Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Lung Cancer Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Lung Cancer Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Lung Cancer Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Lung Cancer Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Lung Cancer Vaccine Sales (K Units) by Application (2017-2022)
Table 45. Global Lung Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Lung Cancer Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Lung Cancer Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Lung Cancer Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. GlaxoSmithKline Corporation Information
Table 50. GlaxoSmithKline Description and Business Overview
Table 51. GlaxoSmithKline Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. GlaxoSmithKline Lung Cancer Vaccine Product
Table 53. GlaxoSmithKline Recent Developments/Updates
Table 54. Oncothyreon Incorporation Corporation Information
Table 55. Oncothyreon Incorporation Description and Business Overview
Table 56. Oncothyreon Incorporation Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Oncothyreon Incorporation Lung Cancer Vaccine Product
Table 58. Oncothyreon Incorporation Recent Developments/Updates
Table 59. Eli Lily Corporation Information
Table 60. Eli Lily Description and Business Overview
Table 61. Eli Lily Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Eli Lily Lung Cancer Vaccine Product
Table 63. Eli Lily Recent Developments/Updates
Table 64. ImClone Systems Corporation Information
Table 65. ImClone Systems Description and Business Overview
Table 66. ImClone Systems Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. ImClone Systems Lung Cancer Vaccine Product
Table 68. ImClone Systems Recent Developments/Updates
Table 69. Boehringer Ingelheim Corporation Information
Table 70. Boehringer Ingelheim Description and Business Overview
Table 71. Boehringer Ingelheim Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Boehringer Ingelheim Lung Cancer Vaccine Product
Table 73. Boehringer Ingelheim Recent Developments/Updates
Table 74. Merck Corporation Information
Table 75. Merck Description and Business Overview
Table 76. Merck Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Merck Lung Cancer Vaccine Product
Table 78. Merck Recent Developments/Updates
Table 79. Ono Pharmaceutical Corporation Information
Table 80. Ono Pharmaceutical Description and Business Overview
Table 81. Ono Pharmaceutical Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Ono Pharmaceutical Lung Cancer Vaccine Product
Table 83. Ono Pharmaceutical Recent Developments/Updates
Table 84. CureVac Corporation Information
Table 85. CureVac Description and Business Overview
Table 86. CureVac Lung Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. CureVac Lung Cancer Vaccine Product
Table 88. CureVac Recent Developments/Updates
Table 89. Production Base and Market Concentration Rate of Raw Material
Table 90. Key Suppliers of Raw Materials
Table 91. Lung Cancer Vaccine Distributors List
Table 92. Lung Cancer Vaccine Customers List
Table 93. Lung Cancer Vaccine Market Trends
Table 94. Lung Cancer Vaccine Market Drivers
Table 95. Lung Cancer Vaccine Market Challenges
Table 96. Lung Cancer Vaccine Market Restraints
Table 97. Global Lung Cancer Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 98. Global Lung Cancer Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 99. Global Lung Cancer Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 100. Global Lung Cancer Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 101. Global Lung Cancer Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 102. Global Lung Cancer Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 103. Global Lung Cancer Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 104. Global Lung Cancer Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 105. Global Lung Cancer Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 106. Global Lung Cancer Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 107. Global Lung Cancer Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 108. Global Lung Cancer Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lung Cancer Vaccine
Figure 2. Global Lung Cancer Vaccine Market Share by Type in 2021 & 2028
Figure 3. Subunit Vaccines Product Picture
Figure 4. Live Attenuated Vaccines Product Picture
Figure 5. Conjugate Vaccines Product Picture
Figure 6. Inactivated Vaccines Product Picture
Figure 7. Recombinant Vector Vaccines Product Picture
Figure 8. Global Lung Cancer Vaccine Market Share by Application in 2021 & 2028
Figure 9. Man
Figure 10. Woman
Figure 11. Global Lung Cancer Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Lung Cancer Vaccine Market Size (2017-2028) & (US$ Million)
Figure 13. Global Lung Cancer Vaccine Sales (2017-2028) & (K Units)
Figure 14. Lung Cancer Vaccine Sales Share by Manufacturers in 2021
Figure 15. Global Lung Cancer Vaccine Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Lung Cancer Vaccine Players: Market Share by Revenue in 2021
Figure 17. Lung Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Lung Cancer Vaccine Sales Market Share by Region (2017-2022)
Figure 19. Global Lung Cancer Vaccine Sales Market Share by Region in 2021
Figure 20. Global Lung Cancer Vaccine Revenue Market Share by Region (2017-2022)
Figure 21. Global Lung Cancer Vaccine Revenue Market Share by Region in 2021
Figure 22. United States Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Lung Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Lung Cancer Vaccine by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Lung Cancer Vaccine
Figure 47. Manufacturing Process Analysis of Lung Cancer Vaccine
Figure 48. Lung Cancer Vaccine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
